Singh A, Singhal K, Choudhary S, Bisati S, Arora M.
Indian J Dermatol. 2014 May;59(3):316. doi: 10.4103/0019-5154.131459.
PMID:24891683
Disabling pansclerotic morphea of childhood poses a high risk of chronic ulceration of the skin and squamous cell carcinoma.
Wollina U, Buslau M, Heinig B, Petrov I, Unger E, Kyriopoulou E, Koch A, Köstler E, Schönlebe J, Haroske G, Doede T, Pramatarov K.
Int J Low Extrem Wounds. 2007 Dec;6(4):291-8. doi: 10.1177/1534734607308731.
PMID:18048875
Challenges in the diagnosis and treatment of disabling pansclerotic morphea of childhood: case-based review.
Soh HJ, Samuel C, Heaton V, Renton WD, Cox A, Munro J.
Rheumatol Int. 2019 May;39(5):933-941. doi: 10.1007/s00296-019-04269-w. Epub 2019 Mar 5.
PMID:30838436
Disabling pansclerotic morphea of childhood with extracutaneous manifestations.
Kura MM, Jindal SR.
Indian J Dermatol. 2013 Mar;58(2):159. doi: 10.4103/0019-5154.108079.
PMID:23716826
Variant STAT4 and Response to Ruxolitinib in an Autoinflammatory Syndrome.
Baghdassarian H, Blackstone SA, Clay OS, Philips R, Matthiasardottir B, Nehrebecky M, Hua VK, McVicar R, Liu Y, Tucker SM, Randazzo D, Deuitch N, Rosenzweig S, Mark A, Sasik R, Fisch KM, Pimpale Chavan P, Eren E, Watts NR, Ma CA, Gadina M, Schwartz DM, Sanyal A, Werner G, Murdock DR, Horita N, Chowdhury S, Dimmock D, Jepsen K, Remmers EF, Goldbach-Mansky R, Gahl WA, O'Shea JJ, Milner JD, Lewis NE, Chang J, Kastner DL, Torok K, Oda H, Putnam CD, Broderick L.
N Engl J Med. 2023 Jun 15;388(24):2241-2252. doi: 10.1056/NEJMoa2202318. Epub 2023 May 31.
PMID:37256972
Disabling pansclerotic morphoea: a century of discovery.
Hua VK, Chang J, Laxer RM, Broderick L.
Br J Dermatol. 2025 Mar 18;192(4):585-596. doi: 10.1093/bjd/ljae443.
PMID:39520387
Deep morphea.
Bielsa I, Ariza A.
Semin Cutan Med Surg. 2007 Jun;26(2):90-5. doi: 10.1016/j.sder.2007.02.005.
PMID:17544960
Disabling pansclerotic morphea of childhood--unusual case and management challenges.